FDA Approved: TRAVATAN Z — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved TRAVATAN Z (travoprost) through an original NDA for reducing intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• TRAVATAN Z (TRAVOPROST)

Snippet

ORIG AP for TRAVATAN Z (TRAVOPROST)